HNX Large Cap Companies By Enterprise Value
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Valuation
| Current Valuation | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | DHT | DHT Holdings | 0.11 | 2.42 | 0.25 | ||
| 2 | INN | Summit Hotel Properties | (0.03) | 1.65 | (0.05) | ||
| 3 | HUT | Hut 8 Corp | (0.14) | 6.33 | (0.88) | ||
| 4 | BVS | Bioventus | (0.11) | 2.81 | (0.31) | ||
| 5 | IPA | Immunoprecise Antibodies | 0.03 | 6.96 | 0.18 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.